Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001362310-09-004193
Filing Date
2009-03-23
Accepted
2009-03-23 15:08:16
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c82962e10vk.htm 10-K 1264732
2 EXHIBIT 21 c82962exv21.htm EX-21 2428
3 EXHIBIT 23.1 c82962exv23w1.htm EX-23.1 2910
4 EXHIBIT 31.1 c82962exv31w1.htm EX-31.1 5799
5 EXHIBIT 31.2 c82962exv31w2.htm EX-31.2 5815
6 EXHIBIT 32.1 c82962exv32w1.htm EX-32.1 3741
7 EXHIBIT 32.2 c82962exv32w2.htm EX-32.2 3751
8 GRAPHIC c82962c8296201.gif GRAPHIC 12504
  Complete submission text file 0001362310-09-004193.txt   1308079
Mailing Address 504 CARNEGIE CENTER PRINCETON NJ 08540-6242
Business Address 504 CARNEGIE CENTER PRINCETON NJ 08540-6242 609-951-6800
PharmaNet Development Group Inc (Filer) CIK: 0001089542 (see all company filings)

EIN.: 592407464 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16119 | Film No.: 09698655
SIC: 8731 Services-Commercial Physical & Biological Research